Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Characterization of hematologic malignancies by flow cytometry.

B Barlogie, P McLaughlin, R Alexanian

    Analytical and Quantitative Cytology and Histology
    |May 1, 1987
    PubMed
    Summary

    Flow cytometry

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

    Leukemia·2018
    Same author

    Drug response prediction in high-risk multiple myeloma.

    Gene·2017
    Same author

    Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

    Nature communications·2017
    Same author

    Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

    Leukemia·2017
    Same author

    NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma.

    Leukemia·2017
    Same author

    Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

    Blood cancer journal·2017

    Area of Science:

    • Hematology
    • Oncology
    • Cell Biology

    Background:

    • Flow cytometry is a powerful technique for analyzing cellular characteristics.
    • Hematologic malignancies involve abnormal cell growth in blood, bone marrow, and lymph nodes.
    • Accurate diagnosis and prognosis are crucial for effective patient management.

    Purpose of the Study:

    • To review the utility of quantitative DNA and RNA content assessment via flow cytometry.
    • To evaluate the diagnostic and prognostic value of flow cytometry in hematologic malignancies.
    • To summarize current findings on leukemias, lymphomas, and myelomas.

    Main Methods:

    • Quantitative assessment of cellular DNA and RNA content using flow cytometry.
    • Analysis of cell surface antigens for understanding malignant transformation and cell regulation.
    • Correlation of DNA/RNA parameters with morphologic groups, drug sensitivity, and prognosis.

    Main Results:

    • DNA and RNA content analysis by flow cytometry provides valuable diagnostic and prognostic information.
    • While cell surface antigens are relevant to cell biology, DNA/RNA parameters show high sensitivity.
    • DNA/RNA parameters effectively distinguish major morphologic groups, predict drug sensitivity, and aid long-term prognosis.

    Conclusions:

    • Quantitative DNA and RNA assessment by flow cytometry is a sensitive tool for hematologic malignancies.
    • This method offers significant insights into diagnosis, prognosis, and treatment response.
    • Findings support the routine use of flow cytometry in managing patients with leukemias, lymphomas, and myelomas.

    Related Experiment Videos